This paper provides a concise overview of pneumonia as a leading infectious cause of hospitalization and death in the United States. It examines the primary microbial sources of infection — bacterial, viral, fungal, and mycoplasmal — and distinguishes between community-acquired and hospital-acquired pathogens. The paper then traces the pathophysiology of pneumonia, explaining how infection compromises alveolar function by flooding air sacs with fluid and mucus, disrupting gas exchange. Finally, it addresses at-risk populations, methods of prevention such as oral hygiene and aerobic exercise, and the clinical challenges posed by antibiotic-resistant and viral strains.
Pneumonia is a lung infection caused by bacteria, viruses, or fungi. The most direct endogenous sources of these microorganisms include infected nasal carriers, sinusitis, oropharyngeal colonization, gastric or tracheal colonization, and hematogenous spread (Alcon, Fabregas, & Torres, 2005). Although much is known about pneumonia, it remains the leading infectious cause of hospitalization and death in the United States ("Pneumonia," n.d.). One reason pneumonia is so prevalent is that the lungs are exposed to approximately ten thousand liters of air each day, as well as small amounts of saliva and occasionally aspirated regurgitation — all of which can contain bacteria, viral and fungal agents, and other pathogens ("Pneumonia," n.d.).
Although pneumonia is contagious via airborne particles shared by infected persons, self-infection is far more common. This is why oral hygiene, nutrition, and other lifestyle factors are central to reducing disease prevalence. When the immune system has already been compromised, the risk for pneumonia rises considerably. The most common bacteria causing pneumonia outside of the hospital setting include Streptococcus pneumoniae (pneumococcus) and Haemophilus influenzae. In hospital settings, the most common strains of pneumonia-causing bacteria include Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli, all of which are highly resilient ("Pneumonia," n.d.).
It is usually not possible to determine which specific pathogen is the culprit, which is why broad-spectrum antibacterial agents can address most bacterial infections. In healthy individuals, these types of microbes do not reach the alveoli due to defense processes such as coughing, and even if they do reach the alveoli, immune cells can generally handle the infection. Unfortunately, viral infections causing pneumonia are more difficult to treat ("Pneumonia," n.d.). More effective antiviral medications are therefore warranted to help minimize infections and prevent fatalities.
"Vulnerable groups and lifestyle prevention strategies"
"Alveolar fluid buildup and disrupted gas exchange"
"Viral, mycoplasmal, and fungal pneumonia compared"
You’re 47% through this paper. Sign up to read the remaining 3 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.